指南与共识腹部CT

基于NCCN指南的胰腺导管腺癌CT可切除性术前评估:聚焦SMA/SMV分支侵犯

Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
指南 / 共识 · Eur Radiol · 2021-03-19

本研究回顾性纳入368例接受 upfront 手术的胰腺腺癌患者,基于2020版NCCN指南评估术前胰腺协议CT判断可切除性的诊断准确性,并与2017版指南比较。结果显示2020版指南可有效分层预后,且对不可切除病例的R0预测优于旧版;在可切除病例中,肿瘤≥3 cm和门静脉接触与切缘阳性独立相关。

要点

  • 2020版NCCN指南对可切除、交界可切除、不可切除的R0率分别为80.8%、67%、10.7%(p<0.001)。
  • 交界可切除3年OS为28.9%,低于可切除的43.6%(p=0.004),高于不可切除的0.0%(p<0.001)。
  • 可切除病例中肿瘤≥3 cm和门静脉接触与切缘阳性独立相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: For patients with pancreatic adenocarcinoma (PAC), adequate determination of disease extent is critical for optimal management. We aimed to evaluate diagnostic accuracy of CT in determining the resectability of PAC based on 2020 NCCN Guidelines.

METHODS: We retrospectively enrolled 368 consecutive patients who underwent upfront surgery for PAC and preoperative pancreas protocol CT from January 2012 to December 2017. The resectability of PAC was assessed based on 2020 NCCN Guidelines and compared to 2017 NCCN Guidelines using chi-square tests. Overall survival (OS) was estimated using the Kaplan-Meier method and compared using log-rank test. R0 resection-associated factors were identified using logistic regression analysis.

RESULTS: R0 rates were 80.8% (189/234), 67% (71/106), and 10.7% (3/28) for resectable, borderline resectable, and unresectable PAC according to 2020 NCCN Guidelines, respectively (p < 0.001). The estimated 3-year OS was 28.9% for borderline resectable PAC, which was significantly lower than for resectable PAC (43.6%) (p = 0.004) but significantly higher than for unresectable PAC (0.0%) (p < 0.001). R0 rate was significantly lower in patients with unresectable PAC according to 2020 NCCN Guidelines (10.7%, 3/28) than in those with unresectable PAC according to the previous version (31.7%, 20/63) (p = 0.038). In resectable PAC, tumor size ≥ 3 cm (p = 0.03) and abutment to portal vein (PV) (p = 0.04) were independently associated with margin-positive resection.

CONCLUSIONS: The current NCCN Guidelines are useful for stratifying patients according to prognosis and perform better in R0 prediction in unresectable PAC than the previous version. Larger tumor size and abutment to PV were associated with margin-positive resection in patients with resectable PAC.

KEY POINTS: • The updated 2020 NCCN Guidelines were useful for stratifying patients according to prognosis. • The updated 2020 NCCN Guidelines performed better in the prediction of margin-positive resection in unresectable cases than the previous version. • Tumor size ≥ 3 cm and abutment to the portal vein were associated with margin-positive resection in patients with resectable pancreatic adenocarcinoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park SJ, Jang S, Han JK, et al. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion. Eur Radiol. 2021. PMID: 33740095. doi:10.1007/s00330-021-07847-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。